Intermediate to long-term follow-up results of INH chemoprophylaxis prior to anti-TNF-alpha therapy in a high-risk area for tuberculosis

Kurt, Ozlem; Kurt, Bahar; Talay, Fahrettin; Tug, Tuncer; Soy, Mehmet; Bes, Cemal; HAYRAN, KADİR

doi:10.1007/s00508-013-0417-0

Intermediate to long-term follow-up results of INH chemoprophylaxis prior to anti-TNF-alpha therapy in a high-risk area for tuberculosis

Kurt O. K. , Kurt B., Talay F., Tug T., Soy M., Bes C., ...More

WIENER KLINISCHE WOCHENSCHRIFT, vol.125, pp.616-620, 2013 (Journal Indexed in SCI)

Publication Type: Article / Article
Volume: 125
Publication Date: 2013
Doi Number: 10.1007/s00508-013-0417-0
Title of Journal : WIENER KLINISCHE WOCHENSCHRIFT
Page Numbers: pp.616-620

Abstract

The use of anti-TNF drugs for rheumatic diseases has increased in recent years. Several studies have reported an increased risk of reactivation of tuberculosis (TB) with anti-TNF agents.